Enpp1 inhibitors as inhibitors of metastasis
AssigneeAngarus Therapeutics, Inc.
InventorsJackie Papkoff, Randolph Mellus Johnson, Neil A. Verity, Nigel Ray, James Johnston
Life of this patent
Estimating the term…
Loading patent…
AssigneeAngarus Therapeutics, Inc.
InventorsJackie Papkoff, Randolph Mellus Johnson, Neil A. Verity, Nigel Ray, James Johnston
Estimating the term…
Methods are provided for the treatment or prevention of metastasis by the inhibition of ENPP1. Aspects of the subject methods include contacting a sample with a cell impermeable ENPP1 inhibitor to treat or prevent metastasis. Aspects of the methods include administering to a subject in need thereof a therapeutically effective amount of an immune checkpoint inhibitor, a chemotherapeutic agent, and/or radiation treatment, in combination with a therapeutically effective amount of a cell impermeable ENPP1 inhibitor to treat or prevent metastasis.
A method of treating, reducing, or preventing metastasis of cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition comprising an ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitor.
(canceled)
(canceled)
Dependencies are inferred from the claim text.